These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Novel treatment options for the management of heterozygous familial hypercholesterolemia. Polychronopoulos G; Tziomalos K Expert Rev Clin Pharmacol; 2017 Dec; 10(12):1375-1381. PubMed ID: 28884604 [TBL] [Abstract][Full Text] [Related]
65. RNA Silencing in the Management of Dyslipidemias. Henney NC; Banach M; Penson PE Curr Atheroscler Rep; 2021 Sep; 23(11):69. PubMed ID: 34468873 [TBL] [Abstract][Full Text] [Related]
66. Efficiency and safety of proprotein convertase subtilisin/kexin 9 monoclonal antibody on hypercholesterolemia: a meta-analysis of 20 randomized controlled trials. Li C; Lin L; Zhang W; Zhou L; Wang H; Luo X; Luo H; Cai Y; Zeng C J Am Heart Assoc; 2015 Jun; 4(6):e001937. PubMed ID: 26077586 [TBL] [Abstract][Full Text] [Related]
67. Reducing cholesterol levels to decrease cardiovascular events: the role of new proprotein convertase subtilisin/kexin type 9 inhibitors. Alberto Z J Cardiovasc Med (Hagerstown); 2017 Jan; 18 Suppl 1():e184-e186. PubMed ID: 27841824 [No Abstract] [Full Text] [Related]
68. Insights into a PCSK9 structural groove: a harbinger of new drugs to reduce LDL-cholesterol. Seidah NG Nat Struct Mol Biol; 2017 Oct; 24(10):785-786. PubMed ID: 28981076 [No Abstract] [Full Text] [Related]
69. Getting Real With PCSK9 Inhibitors in Familial Hypercholesterolemia. Baass A; Hegele RA Can J Cardiol; 2018 Aug; 34(8):959-961. PubMed ID: 30056849 [No Abstract] [Full Text] [Related]
70. Inclisiran: A Game Changer in a Changing Game? Nambi V; Agha A J Am Coll Cardiol; 2021 Mar; 77(9):1194-1196. PubMed ID: 33663736 [No Abstract] [Full Text] [Related]
71. Beyond Statins and PCSK9 Inhibitors: Updates in Management of Familial and Refractory Hypercholesterolemias. Rached F; Santos RD Curr Cardiol Rep; 2021 Jun; 23(7):83. PubMed ID: 34081216 [TBL] [Abstract][Full Text] [Related]
72. Lipid Lowering Drugs: Present Status and Future Developments. Ruscica M; Ferri N; Santos RD; Sirtori CR; Corsini A Curr Atheroscler Rep; 2021 Mar; 23(5):17. PubMed ID: 33694108 [TBL] [Abstract][Full Text] [Related]
73. Estimation of the major cardiovascular events prevention with Inclisiran. Cordero A; Santos-Gallego CG; Fácila L; Rodríguez-Mañero M; Bertomeu-González V; Castellano JM; Seijas-Amigo J; Núñez J; Zuazola P; González-Juanatey JR; Badimon JJ Atherosclerosis; 2020 Nov; 313():76-80. PubMed ID: 33032236 [TBL] [Abstract][Full Text] [Related]
75. A Highly Durable RNAi Therapeutic Inhibitor of PCSK9. Fitzgerald K; White S; Borodovsky A; Bettencourt BR; Strahs A; Clausen V; Wijngaard P; Horton JD; Taubel J; Brooks A; Fernando C; Kauffman RS; Kallend D; Vaishnaw A; Simon A N Engl J Med; 2017 Jan; 376(1):41-51. PubMed ID: 27959715 [TBL] [Abstract][Full Text] [Related]
76. [Proprotein convertase subtilisin/kexin type 9 (PCSK9) and inhibitors]. Avci A; Demir K; Altunkeser BB Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 2():56-67. PubMed ID: 25693363 [TBL] [Abstract][Full Text] [Related]
77. Effect of an siRNA Therapeutic Targeting PCSK9 on Atherogenic Lipoproteins: Prespecified Secondary End Points in ORION 1. Ray KK; Stoekenbroek RM; Kallend D; Leiter LA; Landmesser U; Wright RS; Wijngaard P; Kastelein JJP Circulation; 2018 Sep; 138(13):1304-1316. PubMed ID: 29735484 [TBL] [Abstract][Full Text] [Related]
78. Drug Treatment of Hypercholesterolemia in Older Adults: Focus on Newer Agents. Stoll F; Eidam A; Michael L; Bauer JM; Haefeli WE Drugs Aging; 2022 Apr; 39(4):251-256. PubMed ID: 35278206 [TBL] [Abstract][Full Text] [Related]
79. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors for Treatment of High Cholesterol Levels: Effectiveness and Value. Tice JA; Kazi DS; Pearson SD JAMA Intern Med; 2016 Jan; 176(1):107-8. PubMed ID: 26662572 [No Abstract] [Full Text] [Related]
80. What is the role of PCSK9 inhibitors in treating hypercholesterolemia? Volpe M JAAPA; 2018 Jun; 31(6):14-15. PubMed ID: 29846311 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]